πŸ‡ΊπŸ‡Έ FDA
Patent

US 8377884

Variants of C-type natriuretic peptides

granted A61KA61K38/2242A61K47/60

Quick answer

US patent 8377884 (Variants of C-type natriuretic peptides) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/2242, A61K47/60, A61P, A61P13/12